首页> 美国卫生研究院文献>Breast Cancer Research : BCR >Validation of the prognostic gene portfolio ClinicoMolecular Triad Classification using an independent prospective breast cancer cohort and external patient populations
【2h】

Validation of the prognostic gene portfolio ClinicoMolecular Triad Classification using an independent prospective breast cancer cohort and external patient populations

机译:使用独立的前瞻性乳腺癌队列和外部患者人群验证预后基因组合ClinicoMolecular Triad分类

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionUsing genome-wide expression profiles of a prospective training cohort of breast cancer patients, ClinicoMolecular Triad Classification (CMTC) was recently developed to classify breast cancers into three clinically relevant groups to aid treatment decisions. CMTC was found to be both prognostic and predictive in a large external breast cancer cohort in that study. This study serves to validate the reproducibility of CMTC and its prognostic value using independent patient cohorts.
机译:引言最近,使用前瞻性乳腺癌患者队列的全基因组表达谱,临床分子三分类法(CMTC)得以开发,将乳腺癌分为三个临床相关组以帮助治疗决策。在该研究中,在大型外部乳腺癌队列中发现CMTC具有预后性和预测性。这项研究旨在使用独立的患者队列来验证CMTC的可重复性及其预后价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号